These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21060283)

  • 1. A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty TK; Gangadhar BN
    Clin Neuropharmacol; 2010; 33(6):288-92. PubMed ID: 21060283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nizatidine for the treatment of patients with quetiapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B; Kilic N
    Hum Psychopharmacol; 2004 Jan; 19(1):37-40. PubMed ID: 14716710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trajectories of agouti-related protein and leptin levels during antipsychotic-associated weight gain in patients with schizophrenia.
    Ehrlich S; Leopold K; Merle JV; Theophil I; Haag W; Lautenschlager M; Schaefer M
    J Clin Psychopharmacol; 2012 Dec; 32(6):767-72. PubMed ID: 23131879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
    Haupt DW; Luber A; Maeda J; Melson AK; Schweiger JA; Newcomer JW
    Neuropsychopharmacology; 2005 Jan; 30(1):184-91. PubMed ID: 15367925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia.
    Cortés B; Bécker J; Mories Álvarez MT; Marcos AI; Molina V
    Psychiatry Clin Neurosci; 2014 Feb; 68(2):127-32. PubMed ID: 24552633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
    Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free Fatty acids and glucose metabolism, insulin resistance in schizophrenia with chronic antipsychotics.
    Wang CJ; Zhang ZJ; Sun J; Zhang XB; Mou XD; Zhang XR; Shang XF; Zhang TQ
    Biol Psychiatry; 2006 Dec; 60(12):1309-13. PubMed ID: 16650386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
    Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
    Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol.
    Atmaca M; Kuloglu M; Tezcan E; Gecici O; Ustundag B
    Schizophr Res; 2003 Mar; 60(1):99-100. PubMed ID: 12505146
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
    Janno S; Holi MM; Tuisku K; Wahlbeck K
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.
    Tsuneyama N; Suzuki Y; Sawamura K; Sugai T; Fukui N; Watanabe J; Ono S; Saito M; Someya T
    PLoS One; 2016; 11(3):e0149518. PubMed ID: 26930407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
    Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB
    Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
    Sarandol A; Kirli S; Akkaya C; Ocak N; Eroz E; Sarandol E
    J Psychopharmacol; 2007 Nov; 21(8):857-63. PubMed ID: 17715203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
    Chen CK; Chen YC; Huang YS
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
    Yang J; Bahk WM; Cho HS; Jeon YW; Jon DI; Jung HY; Kim CH; Kim HC; Kim YK; Kim YH; Kwon JS; Lee SY; Lee SH; Yi JS; Yoon BH; Kim SH
    Clin Neuropharmacol; 2010 Jul; 33(4):169-75. PubMed ID: 20661022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.